• Home
  • About
    • What We Do
    • THR In the News
    • Our Founder & Publisher
    • Our History
    • Founding Sponsors
    • Community Partners
    • Advisors
  • Top of Day
  • News
    • Arizona News
    • National News
  • Member Resources
    • Comings & Goings
    • 2022 State of the State Post-Conference Resources
    • Industry Links
    • White Papers, E books, Reports and more
    • Toolbox
  • Professional Directory
    • THR Business Directory
    • Member Directory
    • Founding Sponsors
    • Community Partners
    • Advisors
    • Corporate Profile Intake Form
    • Corporate Profile Change Request
  • Newsletter/Data
    • The Hertel Report March 2026 Newsletter
    • Data Resources
    • Newsletter Archive
  • Events/Products
  • Register
  • Log in
The Hertel Report
  • Contact Us
  • Events
  • Become a Member
  • My Membership
  • My Profile
The Hertel Report
  • Home
  • About
    • What We Do
    • THR In the News
    • Our Founder & Publisher
    • Our History
    • Founding Sponsors
    • Community Partners
    • Advisors
  • Top of Day
  • News
    • Arizona News
    • National News
  • Member Resources
    • Comings & Goings
    • 2022 State of the State Post-Conference Resources
    • Industry Links
    • White Papers, E books, Reports and more
    • Toolbox
  • Professional Directory
    • THR Business Directory
    • Member Directory
    • Founding Sponsors
    • Community Partners
    • Advisors
    • Corporate Profile Intake Form
    • Corporate Profile Change Request
  • Newsletter/Data
    • The Hertel Report March 2026 Newsletter
    • Data Resources
    • Newsletter Archive
  • Events/Products
Home
CMS Rules

CMS Publishes Part II of Guidance for Medicare Prescription Payment Plan

July 17th, 2024 Melanie MacEachern CMS Rules, National News, News

On Tuesday, the Biden administration released guidance on rules for the Medicare Prescription Payment Plan, a key aspect of the healthcare initiatives laid out in the Inflation Reduction Act of 2022 that aims to lower out-of-pocket costs for seniors with Medicare Part D prescription drug coverage.

The program is slated to launch in 2025, and will give those with Medicare drug coverage the option to spread out the costs of their drugs throughout the calendar year instead of paying in full each time they fill a prescription, AJMC explains.

The American Hospital Association (AHA) notes that the guidance is complimentary to guidance published in February and the upcoming national education and implementation effort  will be coordinated between plans, pharmacies, providers, manufacturers and advocacy groups.

In a press release, the Centers for Medicare and Medicaid Services (CMS) says that the program will be opt-in for beneficiaries and will be launched in tandem with the out-of-pocket prescription drug payment cap of $2,000 per year. From CMS Administrator Chiquita Brooks-LaSure:

This new payment option providers people with high Rx spending the option to spread out the costs of their prescription drugs over the calendar year and eliminate the burden of paying the total out-of-pocket cost upfront. CMS is continuing to implement the many important provisions of the Inflation Reduction Act to help people with Medicare access the prescriptions they need.

  • Tags
  • Biden Administration
  • CMS
  • Inflation Reduction Act
  • Medicare Part D
  • Medicare Prescription Payment Plan
  • prescription drug payments
Facebook Twitter Google+ LinkedIn Pinterest
Next article Trump Taps J.D. Vance for VP Nom, Here's Where He Stands on Health Care
Previous article Mayo Clinic Leads Arizona in 2024 Hospital Rankings

Melanie MacEachern

Freelance writer with skills and knowledge in healthcare policy, reproductive justice and art history. Skilled administrative assistant. Graduated from University of Michigan.

Related Posts

National News

Rural Hospital Closures - Issue Brief Points to Low Occupancy, For Profit Status

Reviewing national data from 2012 through 2023, a new ASPE issue brief examined rural hospital closures,...
National News

SCOTUS Rejects Drugmaker Challenge to Medicare Drug Price Negotiation Policy

The U.S. Supreme Court (SCOTUS) shot down cases from AstraZeneca, Johnson & Johnson, Bristol Myers...
National News

TrumpRX Expands Partnerships & Inventory

The Trump administration announced an expansion of the prescription drug discount platform, TrumpRx, through...

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • Home
  • About
  • Top of Day
  • News
  • Member Resources
  • Professional Directory
  • Newsletter/Data
  • Events/Products
  • Back to top
© The Hertel Report 2017. All rights reserved. | Privacy Policy